Mark Purcell
Stock Analyst at Morgan Stanley
(0)
# 4100
Out of 5,311 analysts
5
Total ratings
50.00%
Success rate
-10.13%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NVS Novartis | Initiates Coverage On: Equal-Weight | 114 | 103.88 | 9.74% | 1 | Jan 23, 2024 | |
SNY Sanofi | Initiates Coverage On: Equal-Weight | 55 | 49.7 | 10.66% | 1 | Jan 23, 2024 | |
GSK GSK | Initiates Coverage On: Equal-Weight | 44 | 33.65 | 30.76% | 1 | Jan 23, 2024 | |
AZN AstraZeneca | Initiates Coverage On: Overweight | 85 | 64.9 | 30.97% | 1 | Jan 23, 2024 | |
NVO Novo Nordisk | Initiates Coverage On: Overweight | 120 | 61.1 | 96.4% | 1 | Jan 23, 2024 |